» Authors » Michal Kunc

Michal Kunc

Explore the profile of Michal Kunc including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 263
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zolkiewicz J, Thomas L, Kaminska-Winciorek G, Pastuszak K, Kunc M, Mainska U, et al.
Cancers (Basel) . 2025 Feb; 17(4). PMID: 40002273
Dermoscopy is a non-invasive imaging technique that significantly enhances diagnostic accuracy in diagnosing skin disorders [...].
2.
Kunc M, Skrzypkowska P, Peksa R, Biernat W
Clin Exp Metastasis . 2025 Jan; 42(2):14. PMID: 39890663
Tumor-to-tumor metastasis is an exceedingly rare phenomenon where secondary deposits of a tumor develops in another one. Our systematic review and meta-analysis aims to uncover and analyze reported cases to...
3.
Rydz A, Zolkiewicz J, Kunc M, Slawinska M, Sobjanek M, Nowicki R, et al.
Diagnostics (Basel) . 2025 Jan; 15(1. PMID: 39795638
We present an interesting image of eruptive syringoma confirmed by histopathological assessment in a 37-year-old male who was consulted due to numerous brownish small macules and papules resembling maculopapular cutaneous...
4.
Peksa R, Sharma S, Kunc M, Popeda M, Qu L, Frankiewicz M, et al.
Contemp Oncol (Pozn) . 2024 Nov; 28(3):253-259. PMID: 39512528
Introduction: In clear cell renal cell carcinoma (ccRCC), intravascular extension often results in neoplastic thrombus formation, impacting patient outcomes. Material And Methods: We assessed P-selectin glycoprotein ligand-1 (PSGL-1) expression in...
5.
Forchhammer S, Pop O, Hahn M, Aebischer V, Seitz C, Schroeder C, et al.
Virchows Arch . 2024 Jun; 485(2):335-346. PMID: 38890171
Tumor-associated antigens (TAAs) are potential targets for T cell-based immunotherapy approaches in cutaneous melanoma. BNT111, an investigational lipoplex-formulated mRNA-based therapeutic cancer vaccine encoding melanoma TAAs NY-ESO-1, tyrosinase, MAGE-A3, and TPTE,...
6.
Ciarka A, Kunc M, Popeda M, Lacko A, Radecka B, Braun M, et al.
Contemp Oncol (Pozn) . 2024 May; 28(1):75-83. PMID: 38800535
Introduction: This study aimed to evaluate the impact of tumour-infiltrating lymphocytes (TILs) on the expression of immune-related genes and prognosis in single hormone receptor-positive breast cancer. Material and methods: Tumour-infiltrating...
7.
Ciarka A, Piatek M, Peksa R, Kunc M, Senkus E
Biomedicines . 2024 Apr; 12(4). PMID: 38672117
Tumor-infiltrating lymphocytes (TILs) are pivotal in the immune response against breast cancer (BC), with their prognostic and predictive significance varying across BC subtypes. In triple-negative BC (TNBC), higher TIL levels...
8.
Skowronek F, Ciarka A, Lyzinska W, Piatek M, Peksa R, Kunc M
Pol Arch Intern Med . 2024 Apr; 134(7-8). PMID: 38661583
No abstract available.
9.
Guerrero Z, Melicharova H, Kavanova M, Prokop D, Skvrnak M, Kunc M, et al.
Psychiatry Res . 2023 Oct; 329:115552. PMID: 37864995
Background: We aimed to screen Ukrainian war refugees (UWR) in Czechia for depression and anxiety, and to assess their recognition of personal mental health problems and related help-seeking. Methods: We...
10.
Skrzypkowska P, Kunc M, Biernat W
Contemp Oncol (Pozn) . 2023 Oct; 27(2):118-121. PMID: 37794991
Melanomas are known for their diverse morphological features, presenting a diagnostic challenge for pathologists. Uncommon variations of melanoma can exhibit distinct cytological and histomorphological characteristics, including ganglioneuroblastic differentiation. However, this...